| Ident. | Authors (with country if any) | Title |
|---|
| 001B22 (2010) |
P. Payoux [France] ; C. Brefel-Courbon ; F. Ory-Magne ; W. Regragui ; C. Thalamas ; S. Balduyck ; F. Durif ; J P Azulay ; F. Tison ; O. Blin ; J P Esquerre ; O. Rascol | Motor activation in multiple system atrophy and Parkinson disease: a PET study. |
| 001E63 (2010) |
P. Payoux [France] ; C. Brefel-Courbon [France] ; F. Ory-Magne [France] ; W. Regragui [France] ; C. Thalamas [France] ; S. Balduyck [France] ; F. Durif [France] ; J. P. Azulay [France] ; F. Tison [France] ; O. Blin [France] ; J. P. Esquerre [France] ; O. Rascol [France] | Motor activation in multiple system atrophy and Parkinson disease: A PET study |
| 002963 (2007) |
A. Gerdelat-Mas [France] ; M. Simonetta-Moreau [France] ; C. Thalamas [France] ; F. Ory-Magne [France] ; T. Slaoui [France] ; O. Rascol [France] ; C. Brefel-Courbon [France] | Levodopa raises objective pain threshold in Parkinson’s disease: a RIII reflex study |
| 002A95 (2007) |
A. Gerdelat-Mas [France] ; M. Simonetta-Moreau [France] ; C. Thalamas [France] ; F. Ory-Magne [France] ; T. Slaoui [France] ; O. Rascol [France] ; C. Brefel-Courbon [France] | Levodopa raises objective pain threshold in Parkinson's disease : a Rill reflex study |
| 002C77 (2006) |
J. J. Ferreira [Portugal] ; K. Desboeuf [France] ; M. Galitzky [France] ; C. Thalamas [France] ; C. Brefel-Courbon [France] ; N. Fabre [France] ; J. Senard [France] ; J. Montastruc [France] ; C. Sampaio [Portugal] ; O. Rascol [France] | Sleep disruption, daytime somnolence and ‘sleep attacks’ in Parkinson's disease: a clinical survey in PD patients and age‐matched healthy volunteers |
| 003A63 (2002) |
A. D. Korczyn [Israël] ; C. Thalamas [France] ; C. H. Adler [États-Unis] | Dosing with ropinirole in a clinical setting |
| 003B40 (2001) |
O. Rascol [France] ; J G Nutt ; O. Blin ; C G Goetz ; J M Trugman ; C. Soubrouillard ; J H Carter ; L J Currie ; N. Fabre ; C. Thalamas ; W W Giardina ; S. Wright | Induction by dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson disease. |
| 003B42 (2001) |
O. Rascol [France] ; I. Arnulf ; H. Peyro-Saint Paul ; C. Brefel-Courbon ; M. Vidailhet ; C. Thalamas ; A M Bonnet ; S. Descombes ; B. Bejjani ; N. Fabre ; J L Montastruc ; Yves Agid [France] | Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease. |
| 003B51 (2001) |
S. Descombes [France] ; A M Bonnet ; U E Gasser ; C. Thalamas ; J. Dingemanse ; I. Arnulf ; M P Bareille ; Yves Agid [France] ; O. Rascol | Dual-release formulation, a novel principle in L-dopa treatment of Parkinson's disease. |
| 003B52 (2001) |
O. Rascol [France] ; J J Ferreira ; C. Thalamas ; M. Galitsky ; J L Montastruc | Dopamine agonists. Their role in the management of Parkinson's disease. |
| 003E16 (2001) |
O. Rascol [France] ; J. G. Nutt [États-Unis] ; O. Blin [France] ; C. G. Goetz [États-Unis] ; J. M. Trugman [États-Unis] ; C. Soubrouillard [France] ; J. H. Carter [États-Unis] ; L. J. Currie [États-Unis] ; N. Fabre [France] ; C. Thalamas [France] ; W. J. Giardina [États-Unis] ; S. Wright [États-Unis] | Induction by Dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with parkinson Disease |
| 003E20 (2001) |
O. Rascol [France] ; I. Arnulf [France] ; H. Peyro-Saint Paul [France] ; C. Brefel-Courbon [France] ; M. Vidailhet [France] ; C. Thalamas [France] ; A. M. Bonnet [France] ; S. Descombes [France] ; B. Bejjani [France] ; N. Fabre [France] ; J. L. Montastruc [France] ; Yves Agid [France] | Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease |
| 003E34 (2001) |
S. Descombes [France] ; A. M. Bonnet [France] ; U. E. Gasser [Suisse] ; C. Thalamas [France] ; J. Dingemanse [Suisse] ; I. Arnulf [France] ; M. P. Bareille [France] ; Yves Agid [France] ; O. Rascol [France] | Dual-release formulation, a novel principle in L-dopa treatment of Parkinson's disease |
| 004344 (1999) |
C. Thalamas [France] ; A. Taylor ; C. Brefel-Courbon ; S. Eagle ; K. Fitzpatrick ; O. Rascol | Lack of pharmacokinetic interaction between ropinirole and theophylline in patients with Parkinson's disease. |
| 004376 (1999) |
O. Rascol [France] ; O. Blin ; C. Thalamas ; S. Descombes ; C. Soubrouillard ; P. Azulay ; N. Fabre ; F. Viallet ; K. Lafnitzegger ; S. Wright ; J H Carter ; J G Nutt | ABT-431, a D1 receptor agonist prodrug, has efficacy in Parkinson's disease. |
| 004643 (1999) |
C. Thalamas [France] ; A. Taylor [Royaume-Uni] ; C. Brefel-Courbon [France] ; S. Eagle [Royaume-Uni] ; K. Fitzpatrick [Royaume-Uni] ; O. Rascol [France] | Lack of pharmacokinetic interaction between ropinirole and theophylline in patients with Parkinson's disease |
| 004683 (1999) |
O. Rascol [France] ; O. Blin [France] ; C. Thalamas [France] ; S. Descombes [France] ; C. Soubrouillard [France] ; P. Azulay [France] ; N. Fabre [France] ; F. Viallet [France] ; K. Lafnitzegger [États-Unis] ; S. Wright [États-Unis] ; J. H. Carter [États-Unis] ; J. G. Nutt [États-Unis] | ABT-431, a D1 receptor agonist prodrug, has efficacy in Parkinson's Disease |
| 004729 (1998) |
C. Brefel [France] ; C. Thalamas [France] ; S. Rayet [France] ; A. Lopez-Gil ; K. Fitzpatrick ; S. Bullman [Royaume-Uni] ; D R Citerone [Royaume-Uni] ; A C Taylor [Royaume-Uni] ; J L Montastruc [France] ; O. Rascol [France] | Effect of food on the pharmacokinetics of ropinirole in parkinsonian patients |
| 004911 (1998) |
C. Brefel-Courbon [France] ; C. Thalamas [France] ; H. Peyro Saint Paul [France] ; J.-M. Senard [France] ; J.-L. Montastruc [France] ; O. Rascol [France] | α2-Adrenoceptor antagonists: A new approach to Parkinson's disease? |
| 004958 (1998) |
C. Brefel [France] ; C. Thalamas [France] ; S. Rayet [France] ; A. Lopez-Gil [Royaume-Uni] ; K. Fitzpatrick [Royaume-Uni] ; S. Bullman [Royaume-Uni] ; D. R. Citerone [Royaume-Uni] ; A. C. Taylor [Royaume-Uni] ; J. L. Montastruc [France] ; O. Rascol [France] | Effect of food on the pharmacokinetics of ropinirole in parkinsonian patients |
